Susceptible and protective human leukocyte antigen class II alleles and haplotypes in Bahraini type 2 (non-insulin-dependent) diabetes mellitus patients

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 213-217

  Motala, Ayesha A ^a   Busson, Marc ^b   Al Harbi, Einas M ^c   Khuzam, Manal A A ^e   Al Omari, Emtiaz M D ^e   Arekat, Mona R ^d   Almawi, Wassim Y ^c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b SAINT LOUIS HOSPITAL   (France)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

^d Joslin Diabetes Center Bahrain   (Bahrain)

^e BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; BAHRAIN; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

BAHRAIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED;

EID: 12544253595     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.213-217.2005     Document Type: Article

References (34)

1. Al-Harbi, E. M., A. J. Abbassi, H. Tamim, F. al-Jenaidi, M. Kooheji, M. Kamal, S. al-Mahroos, S., F. al-Nasir, A. A. Motala, and W. Y. Almawi. 2004. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin. Diagn. Lab. Immunol. 11:292-296.
2. al-Mahroos, F., and P. M. McKeigue. 1998. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936-942.
3. Birinci, A., H. Birinci, R. Abidinoglu, B. Durupinar, and I. Oge. 2002. Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus. Eur. J. Ophthalmol. 12:89-93.
4. Bruno, G., A. De Salvia, R. Arcari, M. Borra, N. Grosso, Q. Carta, M. Travati, M. Veglio, and G. Pagano. 1999. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population -based cohort of lean, newly diagnosed patients aged 30-84 years. Piedmont Diabetes Study Group for Diabetes Epidemiology. Diabetes Care 22:50-55.
5. Dittmer, I., G. Woodfield, and I. Simpson. 1998. Non-insulin-dependent diabetes mellitus in New Zealand Maori: a relationship with Class I but not Class II histocompatibility locus antigens. N. Z. Med. J. 111:294-296.
6. Forsblom, C. M., T. Sane, P. H. Groop, K. J. Totterman, M. Kallio, C. Saloranta, L. Laasonen, P. Summanen, M. Lepantalo, L. Laatikainen, E. Matikainen, A. M. Teppo, S. Koskimies, and L. Groop. 1998. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41:1253-1262.
7. Fukui, M., K. Nakano, N. Nakamura, E. Maruya, H. Saji, H. Obayashi, K. Ohta, M. Ohta; H. Mori, S. Kajiyama, S. Wada, Y. Kida, K. Kosaka, M. Deguchi, H. Shigeta, Y. Kitagawa, and M. Kondo. 1998. HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase. J. Clin. Immunol. 18:89-92.
8. Gambelunghe, G., F. Forini, S. Laureti, G. Murdolo, G. Toraldo, F. Santeusanio, P. Brunetti, C. B. Sanjeevi, and A. Falorni. 2000. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. 52:565-573.
9. Ghabanbasani, M. Z., M. Spaepen, I. Buyse, E. Legius, R. Decorte, M. Bex, P. Marynen, R. Bouillon, and J. J. Cassiman. 1995. Increased and decreased relative risk for non-insulin-dependent diabetes mellitus conferred by HLA class II and by CD4 alleles. Clin. Genet. 47:225-230.
10. Gleichmann, H., B. Zorcher, B. Greulich, F. A. Gries, H. R. Henrichs, J. Betrams, and H. Kolb. 1984. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27:S90-S92.
11. Groop, L., S. Koskimies, R. Pelkonen, and E. M. Tolppanen. 1983. Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinol. 104:475-478.
12. Groop, L., A. Miettinen, P. H. Groop, S. Meri, S. Koskimies, and G. F. Bottazzo. 1988. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 37:99-103.
13. Hawarami, K., R. Mohan, V. Mohan, and G. A. Hitman. 1991. A genetic study of retinopathy in South Indian type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:441-444.
14. Hitman, G. A., P. K. Karir, V. Mohan, P. V. Rao, E. M. Kohner, J. C. Levy, and H. Mather, H. 1987. A genetic analysis of type 2 (non-insulin- dependent) diabetes mellitus Punjabi Sikhs and British Caucasoid patients. Diabet. Med. 4:526-530.
15. Horton, V., I. Stratton, G. F. Bottazzo, M. Shattock, I. Mackay, P. Zimmet, S. Manley, R. Holman, and R. Turner. 1999. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 42:608-616.
16. Jabbar, A. A., T. J. Mezaal, and F. H. Dawood. 1989. Association of HLA antigens with diabetes mellitus in an Iraqi population. Dis. Markers 7:79-85.
17. Kawabata, Y., H. Ikegami, Y. Kawaguchi, T. Fujisawa, M. Shintani, M. Ono, M. Nishino, Y. Uchigata, I. Lee, and T. Ogihara. 2002. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51:545-551.
18. Kirk, R. L., P. R. Ranford, S. W. Serjeantson, A. R. Thompson, S. M. Munirathnam Chetty, L. John, V. Mohan, A. Ramachandran, C. Snehalatha, and M. Viswanathan. 1985. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics. Diabetes Res. Clin. Pract. 1:41-47.
19. Li, H., L. Groop, A. Nilsson, J. Weng, and T. Tuomi. 2003. A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 88:2767-2774.
20. Li, H., B. Isomaa, M. R. Taskinen, L. Groop, and T. Tuomi. 2000. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 23:589-594.
21. Li, H., E. Lindholm, P. Almgren, A. Gustafsson, C. Forsblom, L. Groop, and T. Tuomi. 2001. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J. Clin. Endocrinol. Metab. 86:574-582.
22. Obayashi, H., G. Hasegawa, M. Fukui, K. Kamiuchi, A. Kitamura, M. Ogat, T. Kanaitsuka, H. Shigeta, Y. Kitagawa, K. Nakano, M. Nishimura, M. Ohta, and N. Nakamura. 2000. Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies. J. Clin. Endocrinol. Metab. 85:3348-3351.
23. Omar, M. A., M. G. Hammond, A. A. Motala, and M. A. Seedat. 1988. HLA class I and II antigens in South African Indians with NIDDM. Diabetes 37:796-799.
24. Perez-Luque, E., C. Alaez, J. M. Malacara, M. E. Garay, M. E. Fajardo, L. E. Nava, and C. Gorodezky. 2003. Protective effect of DRB1 locus against type 2 diabetes mellitus in Mexican Mestizos. Hum. Immunol. 64:110-118.
25. Perez-Luque, E., J. M. Malacara, A. Olivo-Diaz, C. Alaez, H. Debaz, M. Vazquez Garcia, M. E. Garay, L. E. Nava, A. Burguete, and C. Gordezky. 2000. Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus. Hum. Immunol. 61:1031-1038.
26. Ramachandran, A., C. Snehalatha, E. Tuomilehto-Wolf, G. Vidgren, B. W. Ogunkolade, V. Vijay, and G. A. Hitman. 1999. Type 1 diabetes in the offspring doses not increase the risk of parental type 2 diabetes in South Indians. Diabetes Metab. Res. Rev. 15:328-331.
27. Richens, E. R., N. Abdella, A. K. Jayyab, M. al-Saffar, and K. Behbehani. 1988 Type 2 diabetes in Arab patients in Kuwait. Diabet. Med. 5:231-234.
28. Schneider, S., D. Roessli, and L. Excoffier. 2000. Arlequin version 2.000: a software for population genetics data analysis: http://anthro.unige.ch /arelquin. University of Geneva, Geneva, Switzerland.
29. Serjeantson, S. W., D. Owerbach, P. Zimmet, J. Nerup, and K. Thoma. 1983. Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia 25:13-17.
30. Serjeantson, S. W., D. P. Ryan, P. Ram, and P. Zimmet. 1981. HLA and non-insulin dependent diabetes in Fiji Indians. Med. J. Aust. 1:462-464.
31. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997. Report of the Expert Committee on the Diagnosis and Classifications of Diabetes Mellitus. Diabetes Care 20:1183-1197.
32. Tuomi, T., A. Carlsson, H. Li, B. Isomaa, A. Miettinen, A. Nilsson, M. Nissen, B. O. Ehrnstrom, B. Forsen, B. Snickers, K. Lahti, C. Forsblom, C. Saloranta, M. R. Taskinen, and L. C. Groop. 1999. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157.
33. Williams, R. C., W. C. Knowler, W. J. Butler, D. J. Pettitt, J. R. Lisse, P. H. Bennett, D. L. Mann, A. H. Johnson, and P. I. Terasaki. 1981. HLA-A2 and type 2 diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia 21:460-463.
34. World Health Organization. 1999. Definition, diagnosis and classification of diabetes mellitus: report of W.H.O. consultation. (Publication W.H.O./ NCD/99.2). World Health Organization, Geneva, Switzerland.